- Home
- NNDM vs ORIC Comparison
NNDM vs ORIC Comparison
Compare NNDM & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNDM
- ORIC
- Stock Information
- Founded
- NNDM 2012
- ORIC 2014
- Country
- NNDM Israel
- ORIC United States
- Employees
- NNDM N/A
- ORIC N/A
- Industry
- NNDM Electrical Products
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- NNDM Technology
- ORIC Health Care
- Exchange
- NNDM Nasdaq
- ORIC Nasdaq
- Market Cap
- NNDM 322.3M
- ORIC 362.9M
- IPO Year
- NNDM N/A
- ORIC 2020
- Fundamental
- Price
- NNDM $1.51
- ORIC $4.77
- Analyst Decision
- NNDM
- ORIC Strong Buy
- Analyst Count
- NNDM 0
- ORIC 9
- Target Price
- NNDM N/A
- ORIC $18.43
- AVG Volume (30 Days)
- NNDM 3.2M
- ORIC 969.8K
- Earning Date
- NNDM 06-02-2025
- ORIC 05-05-2025
- Dividend Yield
- NNDM N/A
- ORIC N/A
- EPS Growth
- NNDM N/A
- ORIC N/A
- EPS
- NNDM N/A
- ORIC N/A
- Revenue
- NNDM $57,660,000.00
- ORIC N/A
- Revenue This Year
- NNDM $26.79
- ORIC N/A
- Revenue Next Year
- NNDM N/A
- ORIC N/A
- P/E Ratio
- NNDM N/A
- ORIC N/A
- Revenue Growth
- NNDM 6.85
- ORIC N/A
- 52 Week Low
- NNDM $1.34
- ORIC $3.90
- 52 Week High
- NNDM $2.75
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- NNDM 33.46
- ORIC 37.10
- Support Level
- NNDM $1.34
- ORIC $3.90
- Resistance Level
- NNDM $1.53
- ORIC $5.38
- Average True Range (ATR)
- NNDM 0.08
- ORIC 0.53
- MACD
- NNDM 0.02
- ORIC 0.06
- Stochastic Oscillator
- NNDM 57.57
- ORIC 41.97
About NNDM Nano Dimension Ltd.
Nano Dimension Ltd is a provider of intelligent machines for the fabrication of Additively Manufactured Electronics (AME). High-fidelity active electronic and electromechanical subassemblies are integral enablers of autonomous intelligent drones, cars, satellites, smartphones, and in medical devices. The portfolio of the company includes Mechanical, Chemical, Applications, Industrial Design, and Artificial Learning areas. Nano Dimension machines serve cross-industry needs by depositing proprietary consumable conductive and dielectric materials simultaneously, while concurrently integrating in-situ capacitors, antennas, coils, transformers, and electromechanical components, to function at an unprecedented performance.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.